Buy Huperzine A Bulk Powder Pure Nootropics Cognitive Enhancer For elderly Online CAS 102587-98-4
What is Huperzine A?
Huperzine A is extracted from Huperzia serrata. It is a reversible acetylcholinesterase inhibitor and NMDA receptor antagonist that crosses the blood-brain barrier.
Huperzine A is a naturally occurring sesquiterpene alkaloid compound found in the firmoss Huperzia serrata and in varying quantities in other Huperzia species, including H. elmeri, H. carinat, and H. aqualupian.
Huperzine-A is a cognitive enhancer that inhibits an enzyme that degrades the learning neurotransmitter, acetylcholine; due to this, a relative increase occurs. It belongs to the cholinergics class of molecules, and may be useful in fighting cognitive decline in the elderly. May need to be cycled.
Huperzine A certificate of Analysis
| Product name |
Huperzine A |
| CAS No. |
102587-98-4 |
Outer Packing |
1kg/bag |
| Production date |
21th Jan 2018 |
Shelf life |
20th Jan 2020 |
| Standard adopted |
Enterprise Standard |
| Items of analysis |
Specification |
Results |
| Appearance |
White powder |
Complies |
| Content HPLC |
≥99.0% |
99.2% |
| Water |
≤1% |
0.48% |
| Mesh |
100% above 80 mesh |
Complies |
| Solubility |
Soluble in ethanol |
Complies |
| Heavy metal |
≤10mg/kg |
Complies |
| Pb |
≤1mg/kg |
Complies |
| arsenic |
≤1mg/kg |
Complies |
| HG |
≤1mg/kg |
Complies |
| cadmium |
≤1mg/kg |
Complies |
| Total ash |
≤1% |
Complies |
| Total colonies |
≤1000cfu/g |
Complies |
| Molds and yeasts |
≤100cfu/g |
Complies |
| Salmonella E. coli |
can not be detected |
not detected |
| Solvent remains |
meets the requirments |
Complies |
| Conclusion |
Qualified |
Huperzine A Application
For some years, huperzine A has been investigated as a possible treatment for diseases characterized by neurodegeneration, particularly Alzheimer’s disease
Huperzine A is also marketed as a dietary supplement with claims made for its ability to improve memory and mental function.
Huperzine A has also been postulated as a potential treatment for myasthenia gravis.
Huperzine A Side Effects
Huperzine A may present with mild cholinergic side effects such as nausea, vomiting, and diarrhea. The use of huperzine A during pregnancy and lactation is not recommended due to the lack of sufficient safety data
Huperzine A dosage (how to take)
Supplementation of huperzine-A tends to be in the range of 50-200mcg daily, and while this can be divided into multiple dosages throughout the day it tends to be taken at a single dose. Supplementation of huperzine-A does not require food to be coingested with it and can be taken in a fasted state.
Cycling of huperzine-A tends to be used since it can remain in the body for quite some time (half-life of 10-14 hours), and although a ‘cycle’ of huperzine-A tends to last 2-4 weeks followed by a break the optimal cycle length is not yet known.
